Last reviewed · How we verify
NCT07094594: ARES
ARES Trial: Approach to Resection and Evaluation in Severe Diverticulitis
trial in Diverticular Disease of Colon in 578 participants. Completed in 30 March 2025.
1 January 2025
Quick facts
| Lead sponsor | Azienda Sanitaria Locale Napoli 2 Nord |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 578 |
| Start date | 1 January 2017 |
| Primary completion | 1 January 2025 |
| Estimated completion | 30 March 2025 |
| Sites | 1 location across Italy |
Conditions studied
- Diverticular Disease of Colon — all drugs for Diverticular Disease of Colon →
- Colostomy - Stoma — all drugs for Colostomy - Stoma →
- Loop Ileostomies — all drugs for Loop Ileostomies →
Sponsor
Azienda Sanitaria Locale Napoli 2 Nord
Who can join
18 and older, any sex, with Diverticular Disease of Colon or Colostomy - Stoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This observational study was conducted across five surgical centers in Italy, including both academic and community hospitals, from January 2017 to December 2022. The study aimed to evaluate outcomes in patients with acute perforated sigmoid diverticulitis classified as Hinchey Stage III or IV. All consecutive patients aged 18 years or older who presented with acute perforated sigmoid diverticulitis and underwent emergency colonic resection were included. Patients were excluded if they had Hinchey Stage I or II diverticulitis, postoperative confirmation of malignancy, or underwent laparoscopic surgery. This approach ensured a well-defined patient cohort for consistent and reliable analysis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07094594
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diverticular Disease of Colon
Currently open trials in the same condition.
- NCT06764550 — Molecular and Microbiota Signatures Underlying Colonic Diverticular Disease · active not recruiting
Other Azienda Sanitaria Locale Napoli 2 Nord trials
Trials by the same sponsor.
- NCT07382180 — Real-World Tirzepatide Therapy in Post-Bariatric Weight Regain and Preoperative Obesity Patients · completed
- NCT04749329 — Use of Resorbable Prosthetic Mesh "Ante Rectus" as Prevention of Parastomal Hernia. · NA · unknown
- NCT04471311 — Safety and Efficacy of Prophylactic Re-sorbable Biosynthetic Mesh Following Midline Laparotomy in Clean/Contaminated Fie · NA · unknown
- NCT05632952 — ProSpectic Italian Laparoscopic Hybrid mEsh hErnia Repair in Obese patientS Trials · unknown
- NCT07349628 — Botulinum Toxin A Facilitates Fascial Closure in Complex Incisional Hernias · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07094594 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Sanitaria Locale Napoli 2 Nord
- Last refreshed: 3 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07094594.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing